Urogen Pharma Ltd (URGN)

EBITDA Margin

-4.37%

Quarterly · Period ending:

URGN logo

URGN EBITDA Margin

Latest reported-4.37%
URGN Quarterly EBITDA Margin (0.00% → -4.37%)
High-resolution chart · PNG

URGN ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd EBITDA Margin — Quarterly
Period endingEBITDA Margin
-4.3709%
-37.2908%
-58.641%
-93.7632%
-201.6023%
-191.9917%
-106.8675%
-58.2447%
-135.6692%
-126.5854%
-31.547%
-58.4069%
-94.0915%
-152.4197%
-135.4577%
-136.6279%
-109.0761%
-201.4819%
-120.2176%
-262.1707%
-195.4266%
-343.1663%
-334.4087%
-827.102%
-8,420.6989%
0%
0%
0%
-131,627.7778%
0%
0%
-7,431.4488%
-5,050.2747%
-2,785.8628%
-3,088.685%
-3.661%
0%
-18,384.2105%
79.7604%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.